Clinical Trials Logo
  1. Home
  2. Other
  3. NCT05299372

Telemonitoring in NIV MND (OptNIVent) — OptNIVent  

Motor Neuron Disease, Amyotrophic Lateral Sclerosis Clinical Trial

Official title:
Optimising the Management of Ventilated Patients and Quality of Life in Motor Neurone Disease: a Pilot Study

Clinical Trial Summary

This is a feasibility study of telemonitoring system for people with MND/ALS, who are on NIV, via a call centre operated by a local clinical commissioning group.

Clinical Trial Description

This study will test the feasibility of previously developed Telehealth system, using a device called Careportal®, to monitor people with MND/ALS who are using non-invasive ventilation (NIV). The Careportal® is a CE marked portable tablet computer device allowing telecommunication between patients and their care team through bespoke question sets, overnight oximetry test, and patient-ventilator interaction(PVI) data. Previously, the weekly telemonitoring via Careportal® was found to be an effective method to monitor symptom changes, allowing clinicians to optimise the care of ventilated patients with MND. This study will assess the practicality of using Careportal® in the care of ventilated patients with MND by monitoring patients through a patient support call centre. The call centre will screen the data and liaise with appropriate clinicians regarding changes of symptoms. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05299372
Study type Interventional
Source Liverpool University Hospitals NHS Foundation Trust
Contact Hikari Ando, PhD
Phone 0151529
Email hikari.ando@nhs.net
Status Not yet recruiting
Phase N/A
Start date April 25, 2022
Completion date December 31, 2022
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03604822 - Music Therapy Protocol to Support Bulbar and Respiratory Functions in ALS N/A
Recruiting NCT03100110 - NeuroCognitive Communicator: Safety Study N/A
Recruiting NCT06320444 - Non-invasive Spinal, Cortical, and Sensorimotor Biomarkers in Motor Neurone Disease
Completed NCT03828123 - Autologous Multipotent Mesenchymal Stromal Cells in the Treatment of Amyotrophic Lateral Sclerosis Phase 1/Phase 2
Recruiting NCT04302870 - Motor Neurone Disease - Systematic Multi-Arm Adaptive Randomised Trial Phase 2/Phase 3
Completed NCT03520517 - Open-label Study to Evaluate Safety, Tolerability and PK of BHV-0223 in ALS Phase 1
Recruiting NCT05852405 - Clinical Characteristics, Natural History, Health Care Measures, and Genetic Screening in Patients With ALS
No longer available NCT03537807 - Expanded Access Protocol of BHV-0223 for Patients With Amyotrophic Lateral Sclerosis (ALS)